Literature DB >> 25852148

Robust and sustained immune activation in human Ebola virus infection.

Judith N Mandl1, Mark B Feinberg2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25852148      PMCID： PMC4403214          DOI： 10.1073/pnas.1503864112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  19 in total

Review 1.  Flying under the radar: the immunobiology of hepatitis C.

Authors:  Lynn B Dustin; Charles M Rice
Journal:  Annu Rev Immunol       Date:  2007       Impact factor: 28.527

2.  The role of the Type I interferon response in the resistance of mice to filovirus infection.

Authors:  Mike Bray
Journal:  J Gen Virol       Date:  2001-06       Impact factor: 3.891

3.  Human asymptomatic Ebola infection and strong inflammatory response.

Authors:  E M Leroy; S Baize; V E Volchkov; S P Fisher-Hoch; M C Georges-Courbot; J Lansoud-Soukate; M Capron; P Debré; J B McCormick; A J Georges
Journal:  Lancet       Date:  2000-06-24       Impact factor: 79.321

Review 4.  The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection.

Authors:  Arlene H Sharpe; E John Wherry; Rafi Ahmed; Gordon J Freeman
Journal:  Nat Immunol       Date:  2007-03       Impact factor: 25.606

5.  Human Ebola virus infection results in substantial immune activation.

Authors:  Anita K McElroy; Rama S Akondy; Carl W Davis; Ali H Ellebedy; Aneesh K Mehta; Colleen S Kraft; G Marshall Lyon; Bruce S Ribner; Jay Varkey; John Sidney; Alessandro Sette; Shelley Campbell; Ute Ströher; Inger Damon; Stuart T Nichol; Christina F Spiropoulou; Rafi Ahmed
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-09       Impact factor: 11.205

6.  Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection.

Authors:  F Villinger; P E Rollin; S S Brar; N F Chikkala; J Winter; J B Sundstrom; S R Zaki; R Swanepoel; A A Ansari; C J Peters
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

7.  Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit.

Authors:  A K Rowe; J Bertolli; A S Khan; R Mukunu; J J Muyembe-Tamfum; D Bressler; A J Williams; C J Peters; L Rodriguez; H Feldmann; S T Nichol; P E Rollin; T G Ksiazek
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

8.  Protection from lethal infection is determined by innate immune responses in a mouse model of Ebola virus infection.

Authors:  Siddhartha Mahanty; Manisha Gupta; Jason Paragas; Mike Bray; Rafi Ahmed; Pierre E Rollin
Journal:  Virology       Date:  2003-08-01       Impact factor: 3.616

Review 9.  Pathogenesis of filoviral haemorrhagic fevers.

Authors:  Siddhartha Mahanty; Mike Bray
Journal:  Lancet Infect Dis       Date:  2004-08       Impact factor: 25.071

10.  Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels.

Authors:  Anthony Sanchez; Matthew Lukwiya; Daniel Bausch; Siddhartha Mahanty; Angela J Sanchez; Kent D Wagoner; Pierre E Rollin
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103
View more
  4 in total

1.  The Ebola Outbreak of 2014-2015: From Coordinated Multilateral Action to Effective Disease Containment, Vaccine Development, and Beyond.

Authors:  Thomas R Wojda; Pamela L Valenza; Kristine Cornejo; Thomas McGinley; Sagar C Galwankar; Dhanashree Kelkar; Richard P Sharpe; Thomas J Papadimos; Stanislaw P Stawicki
Journal:  J Glob Infect Dis       Date:  2015 Oct-Dec

2.  Pathogenicity and Virulence of Ebolaviruses with Species- and Variant-specificity.

Authors:  Satoko Yamaoka; Hideki Ebihara
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

Review 3.  Ebola virus disease.

Authors:  Shevin T Jacob; Ian Crozier; William A Fischer; Angela Hewlett; Colleen S Kraft; Marc-Antoine de La Vega; Moses J Soka; Victoria Wahl; Anthony Griffiths; Laura Bollinger; Jens H Kuhn
Journal:  Nat Rev Dis Primers       Date:  2020-02-20       Impact factor: 52.329

4.  Longitudinal characterization of dysfunctional T cell-activation during human acute Ebola infection.

Authors:  C Agrati; C Castilletti; R Casetti; A Sacchi; L Falasca; F Turchi; N Tumino; V Bordoni; E Cimini; D Viola; E Lalle; L Bordi; S Lanini; F Martini; E Nicastri; N Petrosillo; V Puro; M Piacentini; A Di Caro; G P Kobinger; A Zumla; G Ippolito; M R Capobianchi
Journal:  Cell Death Dis       Date:  2016-03-31       Impact factor: 8.469
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.